Olivier Spertini - Concepedia

Author

Olivier Spertini

University Hospital of Lausanne ORCID

Also Known As

O Spertini, O. SPERTINI, O. Spertini, OLIVIER SPERTINI, Olivier Spertini, Olivier spertini, Spertini, Olivier

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

University Hospital of Lausanne University of Lausanne University Hospital of Basel University Hospital of Bern University Hospital of Zurich

About

Olivier Spertini is an author at University Hospital of Lausanne specializing in medicine, immunology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	1.3K
2	Cell Biology	4	4	543
3	Health Sciences	2	2	427
4	Cellular Physiology	2	2	281
5	Biomedical Engineering	1	1	146

Olivier Spertini

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Soluble L-selectin is present in human plasma at high levels and retains functional activity. B Schleiffenbaum, Olivier Spertini, Thomas F. Tedder The Journal of Cell Biology ImmunologyBlood CellPathologyInflammationMolecular Pharmacology	1992	416
Tissue‐specific migration pathways by phenotypically distinct subpopulations of memory T cells Charles R. Mackay, Wendy L. Marston, Lisbeth Dudler, European Journal of Immunology Memory T CellsDevelopmental BiologyNaive T CellsTissue‐specific Migration PathwaysT Cells	1992	249
Monocyte attachment to activated human vascular endothelium in vitro is mediated by leukocyte adhesion molecule-1 (L-selectin) under nonstatic conditions. Olivier Spertini, Francis W. Luscinskas, Michael A. Gimbrone, The Journal of Experimental Medicine Cell AdhesionImmunologyMonocyte AttachmentBiomedical EngineeringImmunotherapy	1992	146
ELISA for quantitation of l-selectin shed from leukocytes in vivo Olivier Spertini, B Schleiffenbaum, Cathy White-Owen, Journal of Immunological Methods Laboratory HematologyAutoimmune DiseaseLaboratory ImmunologyGranulocyteMedicine	1992	122
Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase/Akt pathway Kathrin T. Doepfner, Olivier Spertini, Alexandre Arcaro Leukemia Hematological MalignancySignal TransductionCell RegulationSignaling PathwayReceptor Tyrosine Kinase	2007	115
Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML Bob Löwenberg, Thomas Pabst, Johan Maertens, Blood	2017	96
Modification of P-selectin glycoprotein ligand-1 with a natural killer cell-restricted sulfated lactosamine creates an alternate ligand for L-selectin Pascale André, Olivier Spertini, Sophie Guia, Proceedings of the National Academy of Sciences	2000	93
Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial Bob Löwenberg, Thomas Pabst, Johan Maertens, Blood Advances	2021	65
Elastase and metalloproteinase activities regulate soluble complement receptor 1 release Salima Sadallah, Christoph Hess, Sylvie Miot, European Journal of Immunology	1999	51
Ezrin-Radixin-Moesin-binding Sequence of PSGL-1 Glycoprotein Regulates Leukocyte Rolling on Selectins and Activation of Extracellular Signal-regulated Kinases Bénédicte Baïsse, Olivier Spertini Journal of Biological Chemistry	2012	43

Page 1